Mckesson Corp MCK
We take great care to ensure that the data presented and summarized in this overview for MCKESSON CORP is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding MCK
View all-
Vanguard Group Inc Valley Forge, PA12MShares$6.95 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$6.62 Billion0.15% of portfolio
-
State Street Corp Boston, MA5.88MShares$3.39 Billion0.12% of portfolio
-
Massachusetts Financial Services CO Boston, MA4.94MShares$2.85 Billion0.76% of portfolio
-
Jpmorgan Chase & CO New York, NY3.97MShares$2.29 Billion0.16% of portfolio
-
Geode Capital Management, LLC Boston, MA2.65MShares$1.53 Billion0.11% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.62MShares$1.51 Billion0.78% of portfolio
-
Franklin Resources Inc San Mateo, CA2.51MShares$1.45 Billion0.37% of portfolio
-
Morgan Stanley New York, NY2.49MShares$1.44 Billion0.09% of portfolio
-
Putnam Investments LLC Boston, MA2MShares$1.15 Billion1.27% of portfolio
Latest Institutional Activity in MCK
Top Purchases
Top Sells
About MCK
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Insider Transactions at MCK
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 09
2024
|
Le Ann B Smith EVP & Chief HR Officer |
SELL
Open market or private sale
|
Direct |
579
-28.64%
|
$348,558
$602.81 P/Share
|
Sep 05
2024
|
Brian S. Tyler Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,753
-4.56%
|
$2,105,433
$561.1 P/Share
|
Aug 05
2024
|
Brian S. Tyler Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,753
-4.36%
|
$2,349,378
$626.03 P/Share
|
Jul 31
2024
|
Maria Martinez Director |
BUY
Grant, award, or other acquisition
|
Direct |
349
+50.0%
|
-
|
Jul 31
2024
|
Dominic J Caruso Director |
BUY
Grant, award, or other acquisition
|
Direct |
349
+50.0%
|
-
|
Jul 03
2024
|
Brian S. Tyler Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,753
-4.18%
|
$2,176,740
$580.92 P/Share
|
Jun 11
2024
|
Le Ann B Smith EVP & Chief HR Officer |
SELL
Open market or private sale
|
Direct |
600
-22.88%
|
$351,000
$585.53 P/Share
|
Jun 07
2024
|
Maria Martinez Director |
SELL
Open market or private sale
|
Direct |
483
-100.0%
|
$282,555
$585.88 P/Share
|
Jun 05
2024
|
Brian S. Tyler Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
3,753
-4.01%
|
$2,154,222
$574.41 P/Share
|
May 31
2024
|
Thomas L Rodgers EVP, Chief Strategy & BDO |
SELL
Open market or private sale
|
Direct |
5,232
-67.28%
|
$2,929,920
$560.99 P/Share
|
May 30
2024
|
Brian S. Tyler Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
3,600
-3.7%
|
-
|
May 29
2024
|
Le Ann B Smith EVP & Chief HR Officer |
SELL
Open market or private sale
|
Direct |
202
-7.15%
|
$111,100
$550.0 P/Share
|
May 29
2024
|
Thomas L Rodgers EVP, Chief Strategy & BDO |
SELL
Open market or private sale
|
Direct |
133
-1.68%
|
$73,150
$550.0 P/Share
|
May 29
2024
|
Britt J. Vitalone EVP & CFO |
SELL
Open market or private sale
|
Direct |
2,427
-14.75%
|
$1,334,850
$550.0 P/Share
|
May 28
2024
|
Le Ann B Smith EVP & Chief HR Officer |
SELL
Open market or private sale
|
Direct |
206
-6.8%
|
$114,742
$557.4 P/Share
|
May 28
2024
|
Thomas L Rodgers EVP, Chief Strategy & BDO |
SELL
Open market or private sale
|
Direct |
789
-9.07%
|
$439,473
$557.4 P/Share
|
May 28
2024
|
Britt J. Vitalone EVP & CFO |
SELL
Open market or private sale
|
Direct |
894
-5.15%
|
$497,958
$557.4 P/Share
|
May 25
2024
|
Le Ann B Smith EVP & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
88
-2.82%
|
$49,280
$560.73 P/Share
|
May 25
2024
|
Le Ann B Smith EVP & Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
222
+6.65%
|
-
|
May 25
2024
|
Thomas L Rodgers EVP, Chief Strategy & BDO |
SELL
Payment of exercise price or tax liability
|
Direct |
349
-3.86%
|
$195,440
$560.73 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 104K shares |
---|---|
Exercise of conversion of derivative security | 46K shares |
Open market or private sale | 58.5K shares |
---|---|
Payment of exercise price or tax liability | 52.1K shares |
Bona fide gift | 3.6K shares |